MIT Technology Review
By Carsten T. Charlesworth, Henry T. Greely, Hiromitsu Nakauchi
March 25, 2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation so long? These challenges stem in large part from a common root cause: a severe shortage of ethically sourced human bodies.